Skip to content
by Legal Desire
21 October 2026

Herbert Smith Freehills Kramer advises DKSH on its acquisition of NewBridge Pharmaceuticals

Advising firms

Deal team

18 lawyers named
LawyerFirmSeniorityPracticeOffice
Chris Walters Lead Herbert Smith Freehills Kramer Partner Corporate Middle East
Alan Montgomery Herbert Smith Freehills Kramer Partner Life Sciences Not stated
Anna Szyndler Herbert Smith Freehills Kramer Partner Corporate Not stated
Nicola Halliday Herbert Smith Freehills Kramer Senior associate Not stated Not stated
Faria Ali Herbert Smith Freehills Kramer Senior associate Not stated Not stated
Alex Hamilton Herbert Smith Freehills Kramer Associate Not stated Not stated
Veronica Roberts Herbert Smith Freehills Kramer Not stated Regulatory Not stated
Max Kaufman Herbert Smith Freehills Kramer Not stated Regulatory Not stated
Brigitte Samaha Herbert Smith Freehills Kramer Not stated Regulatory Not stated
Josh Lom Herbert Smith Freehills Kramer Not stated Tax Not stated
James Tryfonos Herbert Smith Freehills Kramer Not stated Tax Not stated
Isha Goel Herbert Smith Freehills Kramer Not stated Tax Not stated
Susannah Cogman Herbert Smith Freehills Kramer Not stated Compliance Not stated
Eleanor Swift Herbert Smith Freehills Kramer Not stated Compliance Not stated
Rebecca Critchley Herbert Smith Freehills Kramer Not stated Compliance Not stated
Clare Wandless Herbert Smith Freehills Kramer Not stated Compliance Not stated
Frank Thompson Herbert Smith Freehills Kramer Not stated Insurance Not stated
Thomas Eden Herbert Smith Freehills Kramer Not stated Insurance Not stated

15 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
DKSHBuy-side
Counterparties
NewBridge Pharmaceuticals (Sell-side)